Skip to main content

Collaborative Research Centre 1278 PolyTarget

In Jena, functional and innovative pharmaceutical polymers for novel drug formulations for the treatment of infectious diseases by targeted modulation of the immune response are being developed as part of a platform strategy.

The aim is the precise and selective modulation of the immune response for an effective treatment of inflammatory and infectious diseases. The developed platform technology will help in preparing for future infections and pandemics as well as overcoming allergic side effects of existing and future drugs and vaccines. You can find more information HERE in the film of the Collaborative Research Centre 1278 PolyTarget.